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Abstract: Disulfide-rich peptides are highly abundant in nature and their study has provided
fascinating insight into protein folding, structure and function. Venomous cone snails belong to
a group of organisms that express one of the largest sets of disulfide-rich peptides (conotoxins)
found in nature. The diversity of structural scaffolds found for conotoxins suggests that specialized
molecular adaptations have evolved to ensure their efficient folding and secretion. We recently
showed that canonical protein disulfide isomerase (PDI) and a conotoxin-specific PDI (csPDI) are
ubiquitously expressed in the venom gland of cone snails and play a major role in conotoxin
folding. Here, we identify cone snail endoplasmic reticulum oxidoreductin-1 (Conus Ero1) and
investigate its role in the oxidative folding of conotoxins through reoxidation of cone snail PDI
and csPDI. We show that Conus Ero1 preferentially reoxidizes PDI over csPDI, suggesting that the
reoxidation of csPDI may rely on an Ero1-independent molecular pathway. Despite the preferential
reoxidation of PDI over csPDI, the combinatorial effect of Ero1 and csPDI provides higher folding
yields than Ero1 and PDI. We further demonstrate that the highest in vitro folding rates of two model
conotoxins are achieved when all three enzymes are present, indicating that these enzymes may
act synergistically. Our findings provide new insight into the generation of one of the most diverse
classes of disulfide-rich peptides and may improve current in vitro approaches for the production of
venom peptides for pharmacological studies.
Keywords: cone snail toxins; disulfide-rich venom peptides; endoplasmic reticulum oxidoreductin-1
(Ero1); protein disulfide isomerase (PDI)
1. Introduction
Formation of correct disulfide bonds is essential for structural stability and functional integrity
of most secreted proteins and peptides. Venom peptides represent one of the largest groups of small,
disulfide-rich peptides found in nature [1]. These peptides have evolved to disrupt the physiology of
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another animal and need to be particularly stable in the extracellular environment. Multiple disulfide
bonds provide the stability and structural integrity necessary for these processes. The venoms of cone
snails are particularly rich in disulfide-rich peptides (termed conotoxins) and provide ideal model
systems to study the molecular processes guiding disulfide-rich peptide folding in the endoplasmic
reticulum (ER) of secretory cells [2,3].
Enzymes of the protein disulfide isomerase (PDI) family are known to play a central role in the
biosynthesis of conotoxins by catalyzing the oxidation of cysteines into their native disulfides and
isomerizing incorrectly formed disulfides into their native connections [2,4,5]. We recently showed that,
in addition to canonical PDI, the venom gland of cone snails harbors a diverse family of specialized
PDIs, termed conotoxin-specific PDIs (csPDIs) that significantly increase the kinetics of oxidative
folding of conotoxins [2]. The PDI and csPDI-catalyzed formation of disulfide bonds involves the
transfer of disulfides from the enzyme to the conotoxin substrate. PDI and csPDI contain two
redox-active sites that are reduced during this process. In order to carry out further oxidations,
these enzymes must be reoxidized.
How the active sites of PDI and csPDI are reoxidized upon conotoxin folding has not been
addressed but has been extensively interrogated in other systems [6,7]. The major enzyme for PDI
reoxidation in the mammalian ER is endoplasmic reticulum oxidoreductin-1 (Ero1) [8]. Ero1 generates
disulfide bonds de novo in conjunction with a flavin adenine dinucleotide (FAD) cofactor and transfers
them to PDI [9]. Ero1 family members are highly conserved proteins that are found from yeast to
human [10]. In vertebrates, a gene duplication of an ancestral Ero1 gene gave rise to two distinct
isoforms, Ero1α and Ero1β, that differ in their structure and tissue distribution [10].
Here, we identify Ero1 from the venom gland of the cone snail Conus geographus and, using
expressed and purified enzymes, we investigate the role of Ero1 in the reoxidation of PDI and csPDI
during the refolding of conotoxins. We show that Ero1 preferentially reoxidizes PDI over csPDI but
that the folding of conotoxins is more efficient in the presence of Ero1 and csPDI over Ero1 and PDI.
We further demonstrate that the highest folding rates are achieved in the presence of all three enzymes
in a synergistic manner. Our findings suggest that PDI and csPDI may act synergistically during the
in vivo folding of conotoxins and/or that csPDI may serve as an Ero1-independent disulfide isomerase
during the oxidative folding of conotoxins.
2. Results
2.1. cDNA Sequencing of Ero1 from the Venom Gland of C. Geographus
PCR sequencing revealed the presence of two distinct Ero1 sequences that were named Conus
Ero1 X1 and X2 based on the naming scheme used for other Ero1-like sequences from mollusks.
The open reading frames (ORFs) of the two cDNA transcripts are 1362 and 1383 nucleotides long,
encoding proteins of 454 and 461 amino acids in length, respectively. Full-length cDNA and predicted
protein sequences have been deposited into the Genbank sequence repository (accession numbers:
Ero1_variant_X1: MK070904 and Ero1_variant_X2: MK070905).
The two predicted Ero1 isoforms only differ by seven amino acids (Figure 1) and share high
amino acid sequence homology to an Ero1 sequence previously identified in the marine mollusk
Aplysia californica (GenBank: XP_012937709, Figure S1). Consistent with this observation, phylogenetic
analysis places both Conus enzymes well within molluskan Ero1 sequences (Figure S2). Despite the
phylogenetic distance between mollusks and vertebrates, comparative alignment with human Ero1α
and Ero1β reveals high sequence conservation; Conus Ero1 X1 and X2 share 98% identity with each
other and, for example, ~48% sequence identity with human Ero1α and Ero1β. They contain the
characteristic pair of shuttle cysteines that reoxidize the active site cysteines of PDI (Figure 1, purple
boxes) and FAD-adjacent cysteines (Figure 1, green boxes) of other Ero1 enzymes. Conus Ero1 X1 and
X2 contain a pair of cysteines in close proximity to the N-terminus that are present in human Ero1α
but absent from Ero1β (Figure 1, orange boxes, Cys 37 and Cys 39) and also contain cysteine 262 that is
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characteristic for Ero1β and absent from Ero1α (Figure 1, red box). Several other residues that have
previously been implicated to play a regulatory role in the human enzymes are also conserved in the
Conus Ero1s [11–14] (Figure 1, blue boxes). Thus, Conus Ero1s share characteristics of both human
Ero1 isoforms.
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Figure 1. Comparative sequence alignment of the two endoplasmic reticulum oxidoreductin-1 (Ero1) 
isoforms identified in Conus geographus (Conus Ero1 X1 and X2) with human Ero1α and Ero1β. 
Predicted signal sequences are shown in gray, cysteines are highlighted in yellow. Conus Ero1 X1 and 
Ero1 X2 differ by seven amino acids (shown in red). Boxes above cysteines are color-coded according 
to their proposed functions [11–14]. The same color scheme is used in the schematic below the 
alignment. Numbering of cysteines is based on the human Ero1α sequence. Sequence alignment was 
generated using Multiple Alignment using Fast Fourier Transform (MAFFT)x [15]. Amino acid 
conservations are denoted by an asterisk (*). Full stops (.) and colons (:) represent a low and high 
degree of similarity, respectively. FAD = flavin adenine dinucleotide; PDI = protein disulfide 
isomerase. 
2.2. Conus Ero1 Expression Yields a Functional, FAD-Binding Enzyme 
Figure 1. Comparative sequence alignment of the two endoplasmic reticulum oxidoreductin-1 (Ero1)
isoforms identified in Conus geographus (Conus Ero1 X1 and X2) with human Ero1α and Ero1β. Predicted
signal sequences are shown in gray, cysteines are highlighted in yellow. Conus Ero1 X1 and Ero1 X2
differ by seven amino acids (shown in red). Boxes above cysteines are color-coded according to their
proposed functions [11–14]. The same color scheme is used in the schematic below the alignment.
Numbering of cysteines is based on the human Ero1α sequence. Sequence alignment was generated
using Multiple Alignment using Fast Fourier Transform (MAFFT)x [15]. Amino acid conservations are
denoted by an asterisk (*). Full stops (.) and colons (:) represent a low and high degree of similarity,
respectively. FAD = flavin adenine dinucleotide; PDI = protein disulfide isomerase.
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2.2. Conus Ero1 Expression Yields a Functional, FAD-Binding Enzyme
Conus Ero1 X1 (hereafter referred to as Ero1) was recombinantly expressed in E. coli for subsequent
functional characterization. Attempts to express the other isoform, Conus Ero1 X2, were not successful
(yields of soluble protein were <0.005 µmol/3 L of bacterial culture).
Recombinant expression of Conus Ero1 yielded a heterogeneous mixture of monomer and higher
molecular weight species that dissociated into the monomer upon reduction with 50 mM dithiothreitol
(DTT) (Figure 2A–C). Size exclusion chromatography (SEC) fractions containing the Ero1 monomer also
comprised the glutathione S-transferase (GST) fusion protein that most likely eluted as a non-covalent
dimer with a similar molecular weight to monomeric Ero1 (50,220 Da). Subsequent purification
using reduced glutathione (GSH)-agarose yielded a final product of ~90% purity that was used
for functional characterization (Figure 2D). Following elution of the GST-Ero1 construct from GSH
agarose, the GST-Ero1 fusion protein appeared bright yellow, suggesting the presence of bound FAD.
Spectrophotometric analysis of Ero1 following PreScission protease cleavage to release GST and
purification revealed absorbance peaks at 370 and 454 nm, consistent with bound FAD at a ratio of
approximately 0.6 FAD molecules/Conus Ero1 (Figure 2E). The final purified Ero1 monomer migrated
as two distinct bands, indicating that Ero1 is expressed in two (partially) oxidized conformations.
The two bands collapsed into a single, slower migrating band after treatment with either an oxidizing
or reducing agent (potassium ferricyanide and DTT, respectively) (Figure 2F).
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Figure 2. Expression and purification of recombinant Conus geographus Ero1 (isoform X1). (A) Size
exclusion chromatography (SEC) chromatogram of reduced glutathione (GSH)-agarose purified Ero1
after proteolytic cleavage from the glutathione S-transferase (GST)-fusion partner. SEC fractions
(colored in green, yellow and blue) were analyzed by (B) non-reducing and (C) reducing SDS-PAGE.
Fractions contai ing the Ero1 mon mer co-elute i ST and required additional GSH-agarose
purification. (D) S S-PAGE of ro1 f llowing GSH-agarose purification. Blue box shows enzyme used
for subs quent characterization. (E) Comparison of the absorbance spectrum of 30 µM Ero1 (in 50 mM
Tris/HCl, 150 mM NaCl, pH 7.5) to that of FAD (20 and 50 µM) suggesting that each Ero1 molecule
binds ~0.6 molecules of FAD. (F) SDS-PAGE analysis of purified Ero1 (left lane) after incubation with a
reducing (dithiothreitol, DTT) and oxidizing (potassium ferricyanide) agent.
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2.3. Conus Ero1 Preferentially Oxidizes PDI Over csPDI
Ero1 uses molecular oxygen as its preferred terminal electron acceptor; thus, oxygen consumption
is a direct indicator for the rate of reoxidation of PDI in buffer containing a reducing reagent [16,17].
To investigate the reactivity of Conus Ero1 with PDI or csPDI, oxygen consumption during the Ero1
catalysis of PDI or csPDI oxidation was measured in the presence of GSH. Oxygen consumption assays
demonstrated that Ero1 oxidized PDI with much higher efficiency than csPDI, indicating that Ero1
is highly specific to PDI (Figure 3). In line with this, Ero1-catalyzed oxidation of PDI was greatly
accelerated by increasing the PDI concentration from 2 to 10 µM, whereas the rate of csPDI oxidation
was little enhanced in this concentration range (Figure 3), suggesting that Conus Ero1 has a much
higher affinity for PDI than for csPDI. Alternatively, PDI may have a much greater ability to activate
Conus Ero1 through disulfide rearrangement than csPDI, which allows the enzyme to oxidize PDI
more efficiently than csPDI [18].
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Figure 3. (A) Oxygen consumption by Ero1 (4 µM) during the oxidation of conotoxin-specific PDI
(csPDI) or PDI (2, 4 or 10 µM each; left, middle and right panel, respectively) in the presence of a
reducing agent (10 mM GSH). (B) Quantification and statistical analyses of the dissolved oxygen
concentration at indicated time points in A (n = 3, means ± standard deviation (SD)). * p < 0.05;
** p < 0.01; *** p < 0.001.
2.4. Conus Ero1 Efficiently Oxidizes PDI but Has Low Reactivity for csPDI
Oxygen consumption assays indicated that Ero1 oxidizes PDI at faster rates than csPDI.
To investi ate the redox st te of PDI and csPDI f llow ng Ero1 exposur , we next monitored
the Ero1-catalyzed id ion of PDI or csPDI in the absence of GSH by non-reducing SDS-PAGE.
Experiments were performed with 4 µM Ero1 and 2 or 10 µM of PDI or csPDI (molar ratio of
Ero1:PDI/csPDI = 1:0.5 and 1:2.5). Again, the reactivity of Ero1 for csPDI appeared l w (Figure 4);
csPDI largely remained in a duced state even after 30 min, whereas PDI was almost entirely
oxidized. Consistent wi h oxygen consu ption ass ys, this finding suggests that Ero1 is highly
specific to PDI with very little activi y towards c PDI. The low reactivity of Ero1 w th cs I suggests
tha while he Ero1–PDI pathway is dedicated to disulfide introduction, csPDI may serve as an
Ero1-independent disulfide isomerase during oxidative folding of conotoxins or that PDI an csPDI
may act synergistically during the folding f conotoxin substrates.
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the in vitro oxidative folding of µ-SmIIIA, a peptide from the venom of Conus stercusmuscarum, is 
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Figure 4. (A) Time course of the redox-state change of PDI or csPDI in the presence of Ero1. Experiments
were performed by mixing the reduced form of PDI or csPDI (2 or 10 µM each) with Ero1 (4 µM)
in air-saturated buffer at 30 ◦C. At the indicated time points, reactions were quenched by adding
maleimide-polyethylene glycol −2k (1 mM). The redox states of PDI and csPDI were analyzed by
non-reducing SDS-PAGE. red = reduced; oxi = oxidized; PO = partially oxidized; black arrow = reduced
Ero1 co-migrating with oxidized PDI. (B) Quantification of the fraction of the reduced form of PDI
or csPDI based on the gel data shown in A (n = 3, means ± SD). (C) Quantification and statistical
analyses of the fraction of the reduced form of csPDI or PDI at the indicated time points in B (n = 3,
means ± SD). *** p < 0.001.
2.5. Conus Ero1 Efficiently Re-Oxidizes PDI and csPDI During the Folding of Conotoxins
To determine whether Conus Ero1 can contribute to conotoxin folding via the reoxidation of Conus
PDI and csPDI, folding assays of two reduced model conotoxin substrates (ω-GVIA and µ-SmIIIA)
were performed in the absence and presence of 4 µM Ero1 and 2 µM PDI or csPDI. ω-GVIA and
µ-SmIIIA belong to the same gene family of conotoxins (the O-superfamily), containing six cysteines
that are connected via three disulfide bonds in the native peptides. ω-GVIA, from the venom of
C. geographus, folds rapidly in vitro with very little misfolded byproduct [19]. In contrast, the in vitro
oxidative folding of µ-SmIIIA, a peptide from the venom of Conus stercusmuscarum, is characterized by
faster kinetics thanω-GVIA but significantly lower final yields [20], thus providing two substrates with
well-characterized but distinct folding characteristics. Two other venom peptides from C. geographus
have been used as model folding substrates in previous studies but were not chosen; µ-GIIIA has very
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similar overall folding kinetics toω-GVIA [2,20], and α-GI has been listed as a dangerous agent by the
US Centers for Disease Control and Prevention [21].
The disappearance of reduced substrate (cysteine oxidation) at early time points of folding
(20 and 16 min after the reaction initiation forω-GVIA and µ-SmIIIA, respectively) and the appearance
of fully folded substrate (oxidation and potential re-shuffling) at the end time point of folding
(100 min and 64 min after the reaction initiation for ω-GVIA and µ-SmIIIA, respectively) were
observed and quantified. PDI or csPDI alone enabled early oxidation of ω-GVIA and µ-SmIIIA
as indicated by the disappearance of the reduced form and were able to catalyze the formation of the
fully folded peptide forω-GVIA, but not for µ-SmIIIA (Figure 5). Consistent with previous findings [2],
csPDI was more efficient in the folding of ω-GVIA when compared to PDI. In the absence of Ero1
and/or GSH/oxidized glutathione (GSSG), some reoxidation of csPDI and PDI likely occurs in the
folding buffer as previously reported [2]. Notably, Ero1 alone affected both the disappearance of the
reduced toxin and the appearance of the fully folded form of µ-SmIIIA and, to a lower extent, also that
of ω-GVIA. Addition of Ero1 to PDI and csPDI significantly increased the rate of disappearance of
the reduced form for both enzymes (p < 0.005, Figure 5A,B, left panels). Similarly, addition of Ero1 to
PDI and csPDI led to significantly higher yields of fully folded ω-GVIA and µ-SmIIIA at the end point
of folding (p < 0.005, Figure 5A,B, right panels), with more efficient folding observed for substrates
incubated with csPDI and Ero1 over PDI and Ero1. Values for statistical analyses are provided in
Table S1.
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Figure 5. Oxidative folding assays of conotoxin (A) ω-GVIA and (B) µ-SmIIIA in the absence and
presence of Ero1 and PDI or csPDI. The disappearance of the reduced form (oxidation reaction) a
the appearance of the fully folded form (oxidation and isomerization reaction) are shown on the left
and right, respectively. Folding assays were carried out in the absence or presence of 2 µM PDI or
2 µM csPDI and 4 µM Ero1 in 100 mM Tris-HCl, 1 mM ethylenediaminetetraacetic acid EDTA, 0.2 mM
FAD, pH 7.5. Folding was initiated by adding 20 µ reduced toxin, which was quenched at different
time points with formic acid and analyzed by reversed-phase chromatography. The area under the
curve was measured for the reduced and fully folded forms. All reactions were carried out in duplicate.
Plotted values represent mean ± SD. Toxin sequences with their native disulfide connectivity are
shown above the graphs. Amino acid code: Z = pyroglutamate, O = hydroxyproline, * = C-terminal
amidation. Values for statistical analyses are provided in Table S2.
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To determine a potential synergistic effect of PDI and csPDI during Ero1-mediated folding,
assays were performed in the presence of Ero1 with either PDI, csPDI or both PDI and csPDI. Initial
experiments using a ratio of 2:1 for Ero1 and PDI/csPDI (4 and 2 µM) showed no synergy between PDI
and csPDI (data not shown). However, when the concentration of PDI/csPDI was changed to 10 µM
(ratio of 1:2.5), the effect of these two enzymes in combination with Ero1 was significantly higher than
the calculated cumulative effect (Figure 6, p < 0.005).
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3. Discussion
The venoms of the approximately 800 species of predatory marine cone snails provide one of
the most diverse sources of disulfide-rich secretory peptides in nature. Toxin expression and folding
takes place in the ER of venom gland cells, where, at any given time, hundreds of distinct cysteine-rich
peptides are properly folded and secreted in preparation for envenomation [3]. While a small subset
of these peptides contains domains that are widely distributed in the animal and plant kingdom
(e.g., the inhibitor cystine knot [22], kunitz-type domains [23], and the insulin/relaxin-like fold [24]),
a large fraction of conotoxins display unique structural domains, expressed only in cone snail venom.
Understanding how these structural scaffolds are efficiently folded is likely to reveal general insights
into the molecular mechanisms of peptide folding. As the proper folding of disulfide-containing
peptides is critical for their biological activity in prey and predator species, the enzymes involved
in these processes play an important role in fitness and survival. PDI is one of the most highly
expressed and abundant soluble enzymes in the venom gland of cone snails, and we recently showed
that the venom gland also harbors a large and diverse gene family of PDI (csPDI) that originated by
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gene duplication from an ancestral PDI gene [2]. Both enzymes appear to play a role in conotoxin
folding [1,2,4,25,26], but the folding of several model conotoxin substrates is more efficient in the
presence of csPDI over PDI [2]. In vitro folding reactions are typically carried out in the presence of a
mixture of reduced and oxidized glutathione (GSH/GSSG), molecules that were long thought to be
paramount for ER-mediated protein folding. However, the discovery of several enzyme-assisted
pathways, including the reoxidation of PDI by the enzyme Ero1 [27,28], dramatically changed
this paradigm.
How members of cone snail PDI and csPDI are reoxidized in vivo had not been addressed,
but recent advances in metagenomics sequencing now allows for the interrogation of candidate
enzymes in the Conus venom gland that are known to play a role in other biological systems. Here,
we sequenced, expressed and functionally characterized Ero1 from the venom gland of the cone snail
C. geographus. Sequences of two different isoforms of Ero1 could be retrieved from C. geographus.
Both showed high sequence homology to other molluskan Ero1-like sequences and only differ from
each other by a short insertion/deletion (indel) of seven amino acids in a flexible loop located between
Cys208 and Cys241 (numbering according to human Ero1α) [14]. Notably, mining of the GenBank
protein database revealed that several other mollusks express Ero1-like sequences that only differ
by having indels in this region (e.g., four and seven different putative isoforms were retrieved from
Aplysia californica and Biomphalaria glabrata, respectively; Figure S1).
To the best of our knowledge, Ero1-like enzymes from invertebrates have not yet been functionally
characterized, but recent studies on human Ero1α suggest that the Cys208–Cys241 pair interacts with
PDI to fine-tune Ero1 activity [12,14]. Thus, the presence of different isoforms of Ero1 with indels
in this flexible loop region suggests potential differences in the regulatory activity between these
isoforms. Attempts to functionally express both isoforms sequenced from C. geographus failed due
to very low yields of soluble, monomeric enzyme for the C. geographus Ero1 isoform X2 (the isoform
containing seven additional residues between Cys208–Cys241). Constructs and conditions used for
Ero1 expression and purification were identical between the two isoforms, suggesting that the low
yield of monomeric Ero1 for isoform X2 was a result of amino acid differences in the Cys208–Cys241
loop region. Future studies are needed to shed light on the role of this region for Conus Ero1 and other
molluskan Ero1-like sequences.
Recombinant expression of Conus Ero1 (isoform X1) provided monomeric as well as dimeric and
oligomeric protein species that collapsed into the monomeric form upon treatment with a disulfide
reducing agent. This is consistent with observations on the bacterial expression of human Ero1 [11,27].
Here, only the monomeric fraction was used for subsequent functional studies.
When tested in oxygen consumption assays in the presence of Conus PDI or csPDI, depletion of
oxygen was highest in the presence of PDI and nearly no oxygen was consumed when csPDI was
present. Gel shift assays confirmed that Conus Ero1 is indeed highly specific for PDI and has very
little oxidation activity towards csPDI. These observations suggest that Ero1 may have a much lower
binding affinity for csPDI compared to PDI, or that their interaction with Ero1 is driven by differences
in the redox state between csPDI and PDI. While the redox state of Conus PDI and csPDI remains to be
determined, we previously noted a conspicuous difference in the +2 position C-terminus of the CGHC
active site motif in both thioredoxin-like catalytic domains (CGHCKK in the catalytic a and a′ domains
in PDI and CGHCKA and CGHCKQ in the a and a′ domains of csPDI, respectively) [2]. We are not
aware of any systematic investigation of the potential functional consequence of mutating residues at
this position, but the close proximity to the active site could well indicate an influence of residues at
this position in modulating the active-site reduction potential and thereby the redox activity of these
enzymes. Future mutational studies at the +2 position C-terminus of the active site of PDI and csPDI
are likely to shed light on how these changes may affect the redox state of these enzymes and their
interaction with Ero1.
Structure–function studies of the interaction between human Ero1 and PDI have shown that
disulfide exchange is facilitated by the binding of a protruding β-hairpin loop of Ero1 to a hydrophobic
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pocket in the b′ domain of PDI [11,29,30]. Homology modeling of Conus PDI and csPDI based on
the crystal structure of human PDI previously demonstrated that while the hydrophobic patch in
the b′ domain of PDI and csPDI remains largely conserved, there is a high degree of variation in the
individual amino acids in the b′ domain, including the hydrophobic pocket [31]. Thus, structural
differences in the b′ domain between PDI and csPDI may result in low binding affinity between Conus
Ero1 and csPDI, which in turn leads to low reoxidation rates when compared to PDI.
The low reactivity of Ero1 with csPDI suggests that while the Ero1–PDI pathway is dedicated
to disulfide introduction, csPDI may serve as an Ero1-independent disulfide isomerase during the
oxidative folding of conotoxins. Oxidative folding assays using two model conotoxin substrates
demonstrated that, despite the low reactivity of Ero1 with csPDI, the combination of these two
enzymes resulted in more efficient folding of the two toxin substrates when compared to the combined
effect of Ero1 and PDI. While csPDI is known to be a more effective foldase of conotoxins than PDI in
buffer systems containing GSH/GSSG [2], the present finding of Ero1-assisted conotoxin refolding in
the absence of GSH/GSSG (but presence of Ero1) was surprising, given that Ero1 had nearly no effect
on the reoxidation of csPDI. Notably, Ero1 alone (without PDI or csPDI) resulted in the oxidation of
both toxin substrates, as observed by the disappearance of the reduced form from the folding mixture
and the appearance of fully folded toxin. One possible explanation that warrants further investigation
could be that Ero1 oxidizes and csPDI isomerizes the peptide.
However, the refolding of both toxins was significantly more efficient in the presence of PDI
and csPDI, with the highest folding yields achieved when all three enzymes were present. In all
cases, the combinatorial effect was higher than the cumulative effect, suggesting that these enzymes
act synergistically. The cooperative interaction between different members of the PDI family was
previously shown for human PDI and the PDI family member P5 during peroxiredoxin-4 mediated
refolding of RNase A [32].
We are not aware of any studies suggesting that Ero1 directly transfers oxidizing equivalents to
PDI-client proteins or any other work examining the direct effect of Ero1 on the folding of small peptide
substrates. While our initial observations on the direct effect of Ero1 on conotoxin folding is intriguing,
it may not be relevant in vivo and requires further testing using other small, cysteine-rich peptides.
It should be noted that the two conotoxin folding substrates used in this study only represent
a small fraction of the structural biodiversity reported in cone snail venoms. Furthermore, these
peptides originated from two different species of cone snail and the efficiency of enzymes sequenced
from C. geographus may be lower for a peptide isolated from another species (i.e., µ-SmIIIA from
C. stercusmuscarum). Ero1-assisted folding studies of a broader range of peptides with diverse structural
scaffolds are likely to shed light on potential species- and peptide-specific folding kinetics.
Here, we present the discovery and initial functional characterization of the first Ero1 enzyme
from the venom gland of cone snails, animals known for their high throughput production of small,
disulfide-rich peptide toxins. Future in-depth characterization of different isoforms of Ero1 from cone
snails and their contribution to the folding of a wider array of peptide toxins is likely to expand our
understanding of the molecular adaptations evolved to facilitate the production of small, structurally
diverse peptides in cone snails and other venomous animals.
4. Materials and Methods
4.1. Specimen Collection
Specimens of Conus geographus were collected from Sogod Island in the Central Philippines.
The venom gland was dissected and stored in RNAlater® (Thermo Fisher Scientific, Waltham, MA,
USA) at −80 ◦C until further processing.
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4.2. Sequencing and Cloning of Ero1
Total RNA was extracted from the venom gland using the RNAEasy MiniKit (Qiagen, Hilden,
Germany). cDNA was synthesized using SMART MMLV reverse transcriptase (Clontech, Palo Alto,
CA, USA) with a 1:1 mixture of oligo dT and random hexamer primers. Oligonucleotides for
amplifying cone snail Ero1 were designed based on a sequence obtained from the venom gland
transcriptome of Conus bullatus [33]. PCR was performed using Advantage 2 DNA polymerase
(Clontech) (Sense: 5′-CGATGTTACAGTTGTCTCTG-3′; Antisense: 5′-CACAGGTGCTGCTCCAAA-3′).
The PCR amplicon was gel-purified, ligated into the pGEM-T Easy vector (Promega, Madison, WI,
USA) and transformed into E. coli DH10B cells (Novagen, Madison, WI, USA). Bacteria containing the
Ero1-encoding plasmid were grown overnight in luria broth (LB) containing 100 µg/mL ampicillin,
and DNA was extracted using the Qiagen miniprep kit. Plasmids isolated from overnight cultures
were sequenced at the University of Utah Sequencing Core Facility. The Ero1 open reading
frame (ORF) lacking the N-terminal signal peptide was amplified from pGEM-T Easy vectors
using Advantage 2 DNA polymerase (Clontech) with oligonucleotides containing BamH1 and Sal1
restriction sites (Sense: 5′-CACACAGGATCCAGTGACAATGTTTCTCAAGGCTG-3′; Antisense:
5′-CACACAGTCGACTCGTCATCTCAGCAAGGCACG-3′). PCR amplicons were cut and inserted
into the pGEX-6P-2 vector containing an N-terminal glutathione S-transferase (GST) tag separated
from the insert by a PreScission Protease cleavage site.
4.3. Expression and Purification of Ero1
The GST–Ero1 fusion construct was expressed in Origami B DE3 competent cells (Novagen).
Overnight cultures were grown in LB medium containing 100 µg/mL ampicillin, 50 µg/mL kanamycin,
and 10 µg/mL tetracycline until the optical density (OD) at 600 nm was 0.6. Cells were induced by
adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 40 µM. Cultures were
shaken at 25 ◦C for 20 h. Cells were lysed by probe sonication in lysis buffer (LBF: 50 mM Tris, 150 mM
NaCl, 1× SigmaFast protease inhibitor tablet (Sigma-Aldrich, St. Louis, MO, USA), pH 7.5), followed
by centrifugation at 20,000× g for 25 min to remove cellular debris. Protein lysates were run twice
over a column containing Pierce Glutathione Agarose (Thermo Fisher Scientific) equilibrated with LBF.
Bound protein was washed with LBF and eluted with LBF containing 10 mM reduced glutathione
(GSH), adjusted to pH 8. GST–Ero1 fusion constructs were dialyzed against LBF using Spectra/Por
1000 molecular weight cut-off dialysis tubing (Spectrum Labs) with two buffer exchanges to remove
glutathione. Cleavage of the GST tag from the Ero1 protein was achieved by incubating with a 1:4 ratio
of PreScission Protease to Ero1 for 4–12 h at 4 ◦C. Following incubation, the mixture was applied to a
column containing Pierce Glutathione Agarose as described above. Ero1 collected in the eluent was
applied to a Superdex 75 size exclusion chromatography (SEC) column (Pharmacia, Pharmacia LKB
Biotechnology AB, Uppsala, Sweden) and eluted in 50 mM Tris-HCl, 150 mM NaCl, pH 7.5. Fractions
were analyzed using reducing (50 mM DTT) and non-reducing SDS-PAGE. Fractions containing the
Ero1 monomer were combined and applied to a column containing Pierce Glutathione Agarose to
remove remaining GST. Protein concentrations were determined using the proteins’ molar extinction
coefficient (51,340 cm−1 M−1). Purified Ero1 lacks the N-terminal signal sequence but has an additional
N-terminal pentapeptide with the sequence GPLGS.
To fully oxidize Conus Ero1, an aliquot of purified enzyme was incubated with 20 mM potassium
ferricyanide for 1 h on ice. Complete reduction was achieved by incubation with 100 mM DTT prior to
analysis by SDS-PAGE.
4.4. Cloning, Expression and Purification of C. Geographus PDI and csPDI
Conus geographus PDI (GenBank: AMM62646) and csPDI (GenBank: AMM62654) were expressed,
purified and quantified as previously described [2].
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4.5. Oxygen Consumption Assay
Oxygen consumption was measured at 30 ◦C using a FireStingO2 fiber-optic oxygen meter
(Pyro Science GmbH, Aachen, Germany) by mixing 2, 4 or 10 µM PDI or csPDI with 4 µM Ero1 in
air-saturated buffer containing 50 mM Tris-HCl (pH 8.1), 150 mM NaCl and 10 mM GSH at 30 ◦C.
4.6. Redox State Analysis of Conus PDI or csPDI in the Presence of Ero1
Conus PDI or csPDI was reduced with 10 mM DTT for 10 min at 4 ◦C, and DTT was removed
using a PD-10 desalting column (GE Healthcare, Chicago, IL, USA). Reduced PDI was incubated
with Conus Ero1 in air-saturated buffer containing 50 mM Tris/HCl (pH 7.5) and 300 mM NaCl at
30 ◦C. At the indicated time points, the reaction was quenched with 1 mM maleimide-PEG-2k [32].
All samples were separated by non-reducing SDS-PAGE followed by staining with Coomassie Brilliant
Blue [12].
4.7. Synthesis of Peptide Substrates for Oxidative Folding Studies
Two model conotoxins were selected for oxidative folding studies because of their
well-characterized folding properties [19,20] and their previous use as a folding substrate for Conus
PDI and csPDI. ω-GVIA is an N-type calcium channel blocker originally isolated from the venom
of C. geographus [34] and µ-SmIIIA is a sodium channel inhibitor isolated from the venom of
C. stercusmuscarum [35]. Peptides were synthesized at the peptide synthesis core facility at the
University of Utah, USA on a solid support by an automated peptide synthesizer (Applied Biosystems
431 Peptide Synthesizer) using Fmoc (N-(9-fluorenyl) methoxycarbonyl) protected amino acids, HBTU
(O-(benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), and diisopropylethylamine.
Peptides were cleaved from the resin by treatment with reagent K (trifluoroacetic acid
(TFA)/thioanisole/ethanedithiol/water/phenol (82.5/5/2.5/5/5 by volume)) for 3.5 and 2.5 h for
ω-GVIA and µ-SmIIIA, respectively. The peptides were subsequently filtered, precipitated and washed
with cold methyl tert-butyl ether. Linear peptides were purified by reversed-phase high performance
liquid chromatography (RP-HPLC) on a semi-preparative C18 column (Vydac, 5µm particle size,
10 mm × 250 mm, Grace) using a linear gradient from 5–50% buffer B (90% acetonitrile (ACN)/0.1%
trifluoroacetic acid (TFA)) over 45 min. Buffer A was 0.1% TFA/water. Absorbance was monitored at
220 and 280 nm. Concentrations were determined spectrophotometrically using the peptides’ molar
absorption coefficient at 280 nm (without disulfide bonds). The purity and correct molecular mass
of the final synthetic material were verified by RP-HPLC and mass spectrometry. Correctly folded
peptide standards were obtained from the peptide synthesis facility at the Salk Institute, CA, USA.
4.8. Oxidative Folding Assays
Folding assays using recombinant Conus PDI, Conus csPDI (expressed and purified as previously
described [2]) and Conus Ero1 were performed in aerated folding buffer (75 mM Tris-HCl, 1 mM EDTA,
0.2 mM FAD) containing (a) no enzyme, (b) 2 µM of PDI or csPDI and (c) 2 µM of PDI or csPDI and
4 µM Ero1.
To investigate potential synergistic effects, folding reactions were performed in the presence
of (a) Ero1 and PDI, (b) Ero1 and csPDI, and (c) Ero1 and PDI in combination with csPDI. In these
experiments, Ero1 was used at a concentration of 4 µM, and PDI and csPDI were tested at either 2 or
10 µM.
All reactions were incubated at room temperature for 20 min and initiated by adding 20 µM
reduced, synthetic conotoxin substrate (ω-GVIA or µ-SmIIIA). Reactions were quenched at different
time points by adding formic acid (10% final) and analyzed by RP-HPLC as described previously [2].
Briefly, native peptides were distinguished from linear forms based on their characteristic elution
profiles [19,20], by comparing the elution profiles to native standard peptides and by mass
spectrometric (MS) analysis of manually collected reversed-phase fractions (MALDI-TOF mass
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spectrometer, positive reflector mode, Voyager, AB SCIEX, Applied Biosystems, Foster City, CA,
USA). To determine the amount of linear and native peptide, the area under the curve was calculated
at each time point (n = 2 for each time point, mean ± SD).
4.9. Statistical Analysis
For oxygen consumption assays (Figure 3) and redox state analysis (Figure 4), statistical analysis
calculated by one-way or two-way analysis of variance (ANOVA) with Tukey HSD (honestly
significance difference) post hoc testing. All statistical tests were performed using KaleidaGraph
software (Synergy Software, Reading, PA, USA) at a significance level of α = 0.05. For oxidative folding
studies, early and late time points of folding (Figure 5) were analyzed using two-tailed Student’s t-tests
with unequal variance (Welch’s correction) using GraphPad Prism software (version 7). For statistical
analysis of different time points of folding (Figure 6), data was analyzed using two-way ANOVA with
time and treatment as independent variables using GraphPad Prism software (version 7).
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Abbreviations
ACN acetonitrile
csPDI conotoxin-specific protein disulfide isomerase
DTT dithiothreitol
ER endoplasmic reticulum
Ero1 endoplasmic reticulum oxidoreductin-1
FAD flavin adenine dinucleotide
Fmoc N-(9-fluorenyl)methoxycarbonyl
HBTU O-(benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
ORF open reading frame
PDI protein disulfide isomerase
RP-HPLC reversed-phase high performance liquid chromatography
SEC size exclusion chromatography
TFA trifluoroacetic acid
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